ArticleJACC. Case reports2025
Hybrid Valve Replacement for Severe Right Ventricular Outflow Tract Dilatation With a Self-Expanding Valve.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hybrid Perventricular Venus P-Valve Implantation Via Mini-Thoracotomy in a Patient With Mechanical Tricuspid Valve.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRight ventricular outflow tract (RVOT) dysfunction as a consequence of conotruncal surgery in congenital heart disease is a common scenario where percutaneous and surgical pulmonary valve replacement (PVR) has been proven as an effective treatment. CASE SUMMARY: Severe dilated RVOT dysfunction due to pulmonary insufficiency was addressed by hybrid pulmonary valve replacement (HPVR). An off-pump RVOT plication was done by sternotomy; thereafter, percutaneous PVR was done. DISCUSSION: Percutaneous PVR has anatomic limitations in complex RVOT dysfunction. Surgical PVR is associated with prolonged hospital stays, need for blood transfusions, inotropic support, and increased risk of ventricular arrhythmias compared with percutaneous PVR. HPVR enables treatment of complex RVOT, reducing surgery morbidity and overcoming the anatomic limitations of percutaneous PVR. To our knowledge, these is the first case published of this autoexpansible valve by HPVR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.